Selective Tyk2 inhibitors as potential therapeutic agents: a patent review (2015-2018)

He, XR; Chen, XB; Zhang, HC; Xie, T; Ye, XY

Xie, T; Ye, XY (reprint author), Hangzhou Normal Univ, HIPI, Sch Med, Hangzhou 311121, Zhejiang, Peoples R China.

EXPERT OPINION ON THERAPEUTIC PATENTS, 2019; 29 (2): 137